Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Buy Now $15.00
Standard view
Full view
of .
Look up keyword
Like this
4Activity
P. 1
Stanislaw R. Burzynski, MD, PhD: Novel Cancer Research and the Fight to Prove Its Worth

Stanislaw R. Burzynski, MD, PhD: Novel Cancer Research and the Fight to Prove Its Worth

Ratings: (0)|Views: 483 |Likes:
Stanislaw R. Burzynski, MD, PhD, graduated with distinction from the Medical Academy in Lublin, Poland, in 1967. During the same year he identified naturally occurring peptides in the human body which he concluded control cancer growth. He found that there is a marked deficiency of these peptides in cancer patients.
In 1968, he earned his doctorate in biochemistry. From 1970 to 1977, while a researcher and assistant professor at Baylor College of Medicine in Houston, his research was sponsored and partially funded by the National Cancer Institute. At Baylor, he authored and coauthored 16 publications, including five concerning his research on peptides and their effect on human cancer. Four of these publications were also coauthored by other doctors associated with MD Anderson Hospital and Tumor Institute and Baylor College of Medicine. It was at Baylor that Dr Burzynski named these peptides “antineoplastons” due to their activity in correcting and normalizing neoplastic, or cancerous, cells.
In 1977, Dr Burzynski founded his clinic in Houston where he’s since treated over 15 000 patients. He is also the president of the Burzynski Research Institute, where he continues to pursue scientific research on antineoplastons. He is the author and coauthor of over 300 scientific publications and presentations. He holds 242 patents registered in 35 countries, related to proprietary scientific inventions.
Stanislaw R. Burzynski, MD, PhD, graduated with distinction from the Medical Academy in Lublin, Poland, in 1967. During the same year he identified naturally occurring peptides in the human body which he concluded control cancer growth. He found that there is a marked deficiency of these peptides in cancer patients.
In 1968, he earned his doctorate in biochemistry. From 1970 to 1977, while a researcher and assistant professor at Baylor College of Medicine in Houston, his research was sponsored and partially funded by the National Cancer Institute. At Baylor, he authored and coauthored 16 publications, including five concerning his research on peptides and their effect on human cancer. Four of these publications were also coauthored by other doctors associated with MD Anderson Hospital and Tumor Institute and Baylor College of Medicine. It was at Baylor that Dr Burzynski named these peptides “antineoplastons” due to their activity in correcting and normalizing neoplastic, or cancerous, cells.
In 1977, Dr Burzynski founded his clinic in Houston where he’s since treated over 15 000 patients. He is also the president of the Burzynski Research Institute, where he continues to pursue scientific research on antineoplastons. He is the author and coauthor of over 300 scientific publications and presentations. He holds 242 patents registered in 35 countries, related to proprietary scientific inventions.

More info:

Published by: InnoVision Health Media on May 23, 2012
Copyright:Traditional Copyright: All rights reserved
List Price: $15.00 Buy Now

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
See more
See less

07/01/2013

$15.00

USD

pdf

You're Reading a Free Preview
Pages 2 to 8 are not shown in this preview.

Activity (4)

You've already reviewed this. Edit your review.
1 hundred reads
1 thousand reads
guroten liked this
Roger Sanders liked this

You're Reading a Free Preview

Download
scribd
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->